Sign in

CIK 0001281895

  • Non-accelerated filer
  • Smaller reporting company

ROCKET PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RCKT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 646-440-9100
Business address
350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
Former names
INOTEK PHARMACEUTICALS CORP
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market sale CEO sold 4,122 shares at $21.38 ($88,108)
  9. 4 Open-market sale Patel Kinnari sold 1,330 shares at $21.38 ($28,429)
  10. 4 Open-market sale Militello John sold 245 shares at $21.38 ($5,237)
  11. 4 Exercise or conversion CEO acquired 7,979 shares (option exercise)
  12. 4 Exercise or conversion Militello John acquired 725 shares (option exercise)
  13. 4 Exercise or conversion Patel Kinnari acquired 3,989 shares (option exercise)
  14. 4 Open-market sale Militello John sold 2,342 shares at $18.65 ($43,678)
  15. 4 Exercise or conversion Militello John acquired 6,364 shares (option exercise)
  16. 4 Grant or award Chief Medical Officer acquired 76,662 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Other acquisition 10% owner acquired 529,038 shares (other)
  19. 4 Open-market sale Schwartz Jonathan David sold 3,557 shares at $19.06 ($67,796)
  20. 4 Open-market sale Militello John sold 1,244 shares at $19.06 ($23,711)

Page 10 of 21 · 408 filings